These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 18464116)

  • 1. Ikaros dominant negative isoform (Ik6) induces IL-3-independent survival of murine pro-B lymphocytes by activating JAK-STAT and up-regulating Bcl-xl levels.
    Kano G; Morimoto A; Takanashi M; Hibi S; Sugimoto T; Inaba T; Yagi T; Imashuku S
    Leuk Lymphoma; 2008 May; 49(5):965-73. PubMed ID: 18464116
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High frequency of Ikaros isoform 6 expression in acute myelomonocytic and monocytic leukemias: implications for up-regulation of the antiapoptotic protein Bcl-XL in leukemogenesis.
    Yagi T; Hibi S; Takanashi M; Kano G; Tabata Y; Imamura T; Inaba T; Morimoto A; Todo S; Imashuku S
    Blood; 2002 Feb; 99(4):1350-5. PubMed ID: 11830486
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumor-derived Ikaros 6 acetylates the Bcl-XL promoter to up-regulate a survival signal in pituitary cells.
    Ezzat S; Zhu X; Loeper S; Fischer S; Asa SL
    Mol Endocrinol; 2006 Nov; 20(11):2976-86. PubMed ID: 16873443
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Overexpression of the Ikaros 6 isoform is restricted to t(4;11) acute lymphoblastic leukaemia in children and infants and has a role in B-cell survival.
    Ruiz A; Jiang J; Kempski H; Brady HJ
    Br J Haematol; 2004 Apr; 125(1):31-7. PubMed ID: 15015965
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dominant-negative IKAROS enhances IL-3-stimulated signaling in wild-type but not BCR-ABL1(+) mouse BA/F3 cells.
    von Palffy S; Bulaeva E; Babovic S; Kannan N; Knapp DJ; Wei L; Eaves CJ; Beer PA
    Exp Hematol; 2015 Jul; 43(7):514-23.e1-2. PubMed ID: 25951974
    [TBL] [Abstract][Full Text] [Related]  

  • 6. BCR-ABL1 induces aberrant splicing of IKAROS and lineage infidelity in pre-B lymphoblastic leukemia cells.
    Klein F; Feldhahn N; Herzog S; Sprangers M; Mooster JL; Jumaa H; Müschen M
    Oncogene; 2006 Feb; 25(7):1118-24. PubMed ID: 16205638
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stage specific over-expression of the dominant negative Ikaros 6 reveals distinct role of Ikaros throughout human B-cell differentiation.
    Tonnelle C; Dijon M; Moreau T; Garulli C; Bardin F; Chabannon C
    Mol Immunol; 2009 May; 46(8-9):1736-43. PubMed ID: 19285729
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ikaros antagonizes DNA binding by STAT5 in pre-B cells.
    Heizmann B; Le Gras S; Simand C; Marchal P; Chan S; Kastner P
    PLoS One; 2020; 15(11):e0242211. PubMed ID: 33180866
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of Ikaros isoform 6 in chinese children with acute lymphoblastic leukemia.
    Zhou F; Mei H; Jin R; Li X; Chen X
    J Pediatr Hematol Oncol; 2011 Aug; 33(6):429-32. PubMed ID: 21792038
    [TBL] [Abstract][Full Text] [Related]  

  • 10. IKAROS and CK2 regulate expression of BCL-XL and chemosensitivity in high-risk B-cell acute lymphoblastic leukemia.
    Song C; Ge Z; Ding Y; Tan BH; Desai D; Gowda K; Amin S; Gowda R; Robertson GP; Yue F; Huang S; Spiegelman V; Payne JL; Reeves ME; Gurel Z; Iyer S; Dhanyamraju PK; Xiang M; Kawasawa YI; Cury NM; Yunes JA; McGrath M; Schramm J; Su R; Yang Y; Zhao Z; Lyu X; Muschen M; Payne KJ; Gowda C; Dovat S
    Blood; 2020 Sep; 136(13):1520-1534. PubMed ID: 32396934
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ikaros 6 protects acute lymphoblastic leukemia cells against daunorubicin-induced apoptosis by activating the Akt-FoxO1 pathway.
    Han J; Jin R; Zhang M; Guo Q; Zhou F
    J Leukoc Biol; 2017 Mar; 101(3):675-681. PubMed ID: 27707884
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Ikaros splice isoform, Ikaros 6, immortalizes murine haematopoietic progenitor cells.
    Ruiz A; Williams O; Brady HJ
    Int J Cancer; 2008 Sep; 123(6):1240-5. PubMed ID: 18623087
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interleukin-7 signaling in human B cell precursor acute lymphoblastic leukemia cells and murine BAF3 cells involves activation of STAT1 and STAT5 mediated via the interleukin-7 receptor alpha chain.
    van der Plas DC; Smiers F; Pouwels K; Hoefsloot LH; Löwenberg B; Touw IP
    Leukemia; 1996 Aug; 10(8):1317-25. PubMed ID: 8709637
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Expression and clinical significance of IKZF1 gene IK6 isoform in adult acute lymphoblastic leukemia].
    Yuan T; Zhao XL; Zhang LX; Li QH; Tian Z; Tang KJ; Wang Y; Lin D; Li W; Liu BC; Zhou CL; Wang M; Wang JX; Mi YC
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2013 Jun; 21(3):539-43. PubMed ID: 23815894
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting of heme oxygenase-1 attenuates the negative impact of Ikaros isoform 6 in adult BCR-ABL1-positive B-ALL.
    Lin X; Zou X; Wang Z; Fang Q; Chen S; Huang J; Zhe N; Yu M; Zhang Y; Wang J
    Oncotarget; 2016 Aug; 7(33):53679-53701. PubMed ID: 27447561
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of Ikaros family splicing variants in human hematopoietic lineages.
    Matulić M; Paradzik M; Puskarić BJ; Stipić J; Antica M
    Coll Antropol; 2010 Mar; 34(1):59-62. PubMed ID: 20432734
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Homoharringtonine affects the JAK2-STAT5 signal pathway through alteration of protein tyrosine kinase phosphorylation in acute myeloid leukemia cells.
    Tong H; Ren Y; Zhang F; Jin J
    Eur J Haematol; 2008 Oct; 81(4):259-66. PubMed ID: 18616510
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Overexpression of B7-H3 augments anti-apoptosis of colorectal cancer cells by Jak2-STAT3.
    Zhang T; Jiang B; Zou ST; Liu F; Hua D
    World J Gastroenterol; 2015 Feb; 21(6):1804-13. PubMed ID: 25684945
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The abnormal expression of IKZF1 encoded protein-IKAROS in B-ALL children].
    Huang XH; Chen J; Li BS
    Zhongguo Dang Dai Er Ke Za Zhi; 2013 Sep; 15(9):743-7. PubMed ID: 24034916
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Disruption of IKAROS activity in primitive chronic-phase CML cells mimics myeloid disease progression.
    Beer PA; Knapp DJ; Miller PH; Kannan N; Sloma I; Heel K; Babovic S; Bulaeva E; Rabu G; Terry J; Druker BJ; Loriaux MM; Loeb KR; Radich JP; Erber WN; Eaves CJ
    Blood; 2015 Jan; 125(3):504-15. PubMed ID: 25370416
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.